• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Sinovac Biotech Ltd

+ Add to Watchlist

SVA:US

5.5500 USD 0.0700 1.28%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Sinovac Biotech Ltd (SVA)

Open: 5.4600 Day's Range: 5.4600 - 5.5900 Volume: 124,430
Previous Close: 5.4800 52wk Range: 3.8000 - 8.1400 1-Yr Rtn: +36.36%

Stock Chart for SVA

No chart data available.
  • SVA:US 5.5500
  • 1D
  • 1M
  • 1Y
5.4800
Interactive SVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SVA

Current P/E Ratio (ttm) 34.4721
Estimated P/E(12/2014) -
Relative P/E vs. SPX 1.9146
Earnings Per Share (USD) (ttm) 0.1610
Est. EPS (USD) (12/2014) -0.0300
Est. PEG Ratio -
Market Cap (M USD) 305.76
Shares Outstanding (M) 55.09
30 Day Average Volume 196,364
Price/Book (mrq) 2.4044
Price/Sale (ttm) 4.0431
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SVA

Sinovac Biotech Ltd. researches, develops, manufactures, and markets various vaccines, including flu vaccines and vaccines for Hepatitis A. The Company's products are sold in the Peoples Republic of China and other countries.

Weidong YinChairman/Pres/CEO/Secy/FounderNan WangChief Financial Officer
Ming XiaVP:Sales & Marketing
More Company Profile & Key Executives for SVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil